ANIP - ANI Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5952.96M
Enterprise Value 31.07B
Trailing P/E 68.96
Forward P/E 112.83
PEG Ratio (5 yr expected) 14.87
Price/Sales (ttm)4.58
Price/Book (mrq)4.68
Enterprise Value/Revenue 35.14
Enterprise Value/EBITDA 612.81

Trading Information

Stock Price History

Beta (3Y Monthly) 1.79
52-Week Change 315.09%
S&P500 52-Week Change 37.14%
52 Week High 379.18
52 Week Low 336.92
50-Day Moving Average 371.25
200-Day Moving Average 362.85

Share Statistics

Avg Vol (3 month) 3131.57k
Avg Vol (10 day) 3191.44k
Shares Outstanding 512.04M
Float 9.08M
% Held by Insiders 111.39%
% Held by Institutions 181.51%
Shares Short (Jun 14, 2019) 41.13M
Short Ratio (Jun 14, 2019) 47.94
Short % of Float (Jun 14, 2019) 414.48%
Short % of Shares Outstanding (Jun 14, 2019) 49.35%
Shares Short (prior month May 15, 2019) 41.18M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Jul 18, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 6.58%
Operating Margin (ttm)20.11%

Management Effectiveness

Return on Assets (ttm)6.13%
Return on Equity (ttm)7.22%

Income Statement

Revenue (ttm)207.98M
Revenue Per Share (ttm)17.75
Quarterly Revenue Growth (yoy)13.80%
Gross Profit (ttm)136.05M
EBITDA 83.47M
Net Income Avi to Common (ttm)13.54M
Diluted EPS (ttm)1.15
Quarterly Earnings Growth (yoy)-80.00%

Balance Sheet

Total Cash (mrq)38.23M
Total Cash Per Share (mrq)3.24
Total Debt (mrq)187.17M
Total Debt/Equity (mrq)93.72
Current Ratio (mrq)0.92
Book Value Per Share (mrq)16.93

Cash Flow Statement

Operating Cash Flow (ttm)58.44M
Levered Free Cash Flow (ttm)26.21M